Catalyst
Slingshot members are tracking this event:
Discovery Labs (DSCO) Completes Enrollment in AEROSURF Phase 2a Dose Expansion Trial in Premature Infants with Respiratory Distress Syndrome
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| DSCO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 21, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Aerosurf, Phase 2, Infants With Respiratory Distress Syndrome, Kl4 Surfactant
